Annual EBIT
-$17.88 M
-$3.44 M-23.87%
December 31, 2023
Summary
- As of February 7, 2025, LTRN annual earnings before interest & taxes is -$17.88 million, with the most recent change of -$3.44 million (-23.87%) on December 31, 2023.
- During the last 3 years, LTRN annual EBIT has fallen by -$11.97 million (-202.59%).
- LTRN annual EBIT is now -935.54% below its all-time high of -$1.73 million, reached on December 31, 2018.
Performance
LTRN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.18 M
+$228.90 K+4.23%
September 30, 2024
Summary
- As of February 7, 2025, LTRN quarterly earnings before interest & taxes is -$5.18 million, with the most recent change of +$228.90 thousand (+4.23%) on September 30, 2024.
- Over the past year, LTRN quarterly EBIT has dropped by -$1.66 million (-47.00%).
- LTRN quarterly EBIT is now -1040.88% below its all-time high of -$454.00 thousand, reached on March 31, 2019.
Performance
LTRN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$21.20 M
-$1.66 M-8.47%
September 30, 2024
Summary
- As of February 7, 2025, LTRN TTM earnings before interest & taxes is -$21.20 million, with the most recent change of -$1.66 million (-8.47%) on September 30, 2024.
- Over the past year, LTRN TTM EBIT has dropped by -$4.37 million (-25.98%).
- LTRN TTM EBIT is now -4569.05% below its all-time high of -$454.00 thousand, reached on March 31, 2019.
Performance
LTRN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LTRN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.9% | -47.0% | -26.0% |
| 3 y3 years | -202.6% | -24.8% | -77.0% |
| 5 y5 years | -935.5% | -673.4% | -772.9% |
LTRN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.0% | at low | -141.4% | +9.6% | -68.3% | at low |
| 5 y | 5-year | -636.3% | at low | -985.2% | +9.6% | -772.9% | at low |
| alltime | all time | -935.5% | at low | -1040.9% | +9.6% | -4569.1% | at low |
Lantern Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$5.18 M(-4.2%) | -$21.20 M(+8.5%) |
| Jun 2024 | - | -$5.41 M(-5.6%) | -$19.54 M(+1.1%) |
| Mar 2024 | - | -$5.73 M(+17.5%) | -$19.32 M(+8.1%) |
| Dec 2023 | -$17.88 M(+23.9%) | -$4.88 M(+38.4%) | -$17.88 M(+6.2%) |
| Sep 2023 | - | -$3.52 M(-32.1%) | -$16.83 M(+8.9%) |
| Jun 2023 | - | -$5.19 M(+21.1%) | -$15.45 M(+5.4%) |
| Mar 2023 | - | -$4.29 M(+12.0%) | -$14.65 M(+1.5%) |
| Dec 2022 | -$14.43 M(+14.6%) | -$3.83 M(+78.4%) | -$14.43 M(+2.2%) |
| Sep 2022 | - | -$2.15 M(-51.2%) | -$14.12 M(-12.4%) |
| Jun 2022 | - | -$4.39 M(+8.1%) | -$16.12 M(+13.5%) |
| Mar 2022 | - | -$4.07 M(+15.8%) | -$14.21 M(+12.8%) |
| Dec 2021 | -$12.59 M | -$3.51 M(-15.4%) | -$12.59 M(+5.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$4.15 M(+67.4%) | -$11.98 M(+25.7%) |
| Jun 2021 | - | -$2.48 M(+1.1%) | -$9.53 M(+20.9%) |
| Mar 2021 | - | -$2.45 M(-15.3%) | -$7.88 M(+33.4%) |
| Dec 2020 | -$5.91 M(+143.3%) | -$2.90 M(+70.2%) | -$5.91 M(+60.2%) |
| Sep 2020 | - | -$1.70 M(+104.2%) | -$3.69 M(+38.9%) |
| Jun 2020 | - | -$833.40 K(+74.6%) | -$2.66 M(+8.3%) |
| Mar 2020 | - | -$477.30 K(-29.3%) | -$2.45 M(+1.0%) |
| Dec 2019 | -$2.43 M(+40.7%) | -$675.20 K(+0.8%) | -$2.43 M(+38.5%) |
| Sep 2019 | - | -$669.70 K(+6.4%) | -$1.75 M(+61.8%) |
| Jun 2019 | - | -$629.40 K(+38.6%) | -$1.08 M(+138.6%) |
| Mar 2019 | - | -$454.00 K | -$454.00 K |
| Dec 2018 | -$1.73 M | - | - |
FAQ
- What is Lantern Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Lantern Pharma?
- What is Lantern Pharma annual EBIT year-on-year change?
- What is Lantern Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Lantern Pharma?
- What is Lantern Pharma quarterly EBIT year-on-year change?
- What is Lantern Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Lantern Pharma?
- What is Lantern Pharma TTM EBIT year-on-year change?
What is Lantern Pharma annual earnings before interest & taxes?
The current annual EBIT of LTRN is -$17.88 M
What is the all time high annual EBIT for Lantern Pharma?
Lantern Pharma all-time high annual earnings before interest & taxes is -$1.73 M
What is Lantern Pharma annual EBIT year-on-year change?
Over the past year, LTRN annual earnings before interest & taxes has changed by -$3.44 M (-23.87%)
What is Lantern Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of LTRN is -$5.18 M
What is the all time high quarterly EBIT for Lantern Pharma?
Lantern Pharma all-time high quarterly earnings before interest & taxes is -$454.00 K
What is Lantern Pharma quarterly EBIT year-on-year change?
Over the past year, LTRN quarterly earnings before interest & taxes has changed by -$1.66 M (-47.00%)
What is Lantern Pharma TTM earnings before interest & taxes?
The current TTM EBIT of LTRN is -$21.20 M
What is the all time high TTM EBIT for Lantern Pharma?
Lantern Pharma all-time high TTM earnings before interest & taxes is -$454.00 K
What is Lantern Pharma TTM EBIT year-on-year change?
Over the past year, LTRN TTM earnings before interest & taxes has changed by -$4.37 M (-25.98%)